Status:
WITHDRAWN
Stem Cells for Bronchopulmonary Dysplasia
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Collaborating Sponsors:
Children's Hospital of Chongqing Medical University
Chongqing Maternal and Child Health Hospital
Conditions:
Bronchopulmonary Dysplasia
Eligibility:
All Genders
1-3 years
Phase:
EARLY_PHASE1
Brief Summary
Very preterm infants are at high risk to develop to bronchopulmonary dysplasia (BPD) for the lack of effective measures to prevent or ameliorate this common and serious disorder. BPD remains a major c...
Detailed Description
Several studies have shown that transplantation of mesenchymal stem cells (MSCs) in immunocompetent animals attenuates lung injury, such as impaired alveolarization, inflammatory response, increased a...
Eligibility Criteria
Inclusion
- diagnosed with BPD
Exclusion
- parents' rejection
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03378063
Start Date
November 1 2017
End Date
December 30 2022
Last Update
May 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatrics, Daping Hospital, Research Institute of Surgery, Third Military Medical University
Chongqing, Chongqing Municipality, China, 400042